References
- Attama AA, Christel CM. (2008). Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity. Colloids and Surfaces A: Physicochem Eng Aspects 315:189–95
- Attama AA, Müller-Goymann CC. (2006). A critical study of physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oil. Int J Pharm 322:67–78
- Attama AA, Nkemnele MO. (2005). In vitro evaluation of drug release from self micro-emulsifying drug delivery systems using a biodegradable homolipid from Capra hircus. Int J Pharm 304:4–10
- Attama AA, Nzekwe IT, Nnamani PO. (2003). The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm 262:23–8
- Attama AA, Reichl S, Müller-Goyman CC. (2008). Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticles formulation using human cornea construct. Int J Pharm 355:307–13
- Attama AA, Okafor CE, Builders PF, Okorie O. (2009). Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium. Drug Deliv 16:448–57
- Chung-Chin M, Santos JL, Oliveira EV, et al. (2009). Synthesis, ex-vivo and in vitro hydrolysis study of an indoline derivative designed as anti-inflammatory with reduced gastric ulceration properties. Molecules 14:3187–97
- Delporte C, Backhouse N, Erazo S, et al. (2005). Analgesic and anti-inflammatory properties of Proustia pyrifolia. J Ethnopharmacol 99:119–24
- Emmanuel CU, Franklin CK, John DO, et al. (2012). Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo. J Microencap 29:296–307
- He C, Hu Y, Yin L, et al. (2010). Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657–66
- Huang X, Brazel CS. (2001). On the importance and mechanisms of burst release in matrix controlled drug delivery systems. J Control Rel 73:121–36
- Jaspart S, Bertholet P, Piel G, et al. (2007). Solid lipid microparticles as sustained release system for pulmonary drug delivery. Eur J Pharm Biopharm 65:47–56
- Lichtenberger LM. (1995). The hydrophobic barrier of gastrointestinal mucus. Annu Rev Physiol 57:565–83
- Lichtenberger LM, Wang ZM, Romero JJ, Barreto JC. (1994). Certain NSAIDs chemically associate with surface phospholipids: insight into the mechanism and reversal of NSAID-induced gastric injury. Gastroenterology 106:154–8
- Lichtenberger LM, Wang ZM, Romero JJ, et al. (1995). Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID induced gastrointestinal injury. Nat Med 1:54–8
- Luo YF, Chen DW, Ren LX, et al. (2006). Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Rel 114:53–9
- Momoh MA, Adikwu MU. (2008). Evaluation of oral insulin delivery using bovine mucin in non-diabetic rats. J Pharm Res 7:5–9
- Momoh MA, Adikwu MU, Ibezim EC. (2010). Formulation and evaluation the bioadhesive properties of drug delivery system based on PEGylated mucin matrices. Asian Pac J Trop Med 4:412–20
- Momoh AM, Esimone CO. (2012). Phospholipon® 90H (P90H)-based PEGylated microscopic lipospheres delivery system for gentamicin: an antibiotic evaluation. Asian Pac J Trop Biomed 2012:889–94
- Momoh MA, Kenechukwu FC, Attama AA. (2013). Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride. Drug Deliv 20:102–11
- Mukherjee S, Ray S, Thakur RS. (2009). Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci 71:349–58
- Rajashree SC, Harinath NM, Ashok VB. (2011). Synthesis, characterization and evaluation of analgesic and anti-inflammatory activities of some novel indoles. Trop J Pharm Res 10:463–73
- Reithmeier HJ, Herrmann N, Gopferich A. (2001). Development and characterisation of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 218:133–43
- Souto EB, Wissing SA, Barbosa CM, Müller RH. (2004). Development of a controlled release formulation based on SLN and NLCcfor topical clotrimazole delivery. Int J Pharm 278:71– 7
- Tunçay M, Caliş S, Kaş HS, et al. (2000). In vitro and in vivo evaluation of diclofenac sodium loaded albumin microspheres. J Microencap 2:145–55
- Ulberth F, Buchgraber M. (2003). Analytical platforms to assess the authenticity of cocoa butter. Eur J Lipid Sci Technol 105:32–42
- Varshosaz J, Minayian M, Moazen E. (2009). Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. J Liposom Res 20:231–9
- Wallace JL. (1997). Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112:1000–16
- Wallace JL, Bak A, McKnight W, et al. (1998). Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 115:101–9
- Yogeshwar GB, Vandana BP. (2009). Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies. AAPS Pharm Sci Tech 10:476–81
- Yuan H, Chen J, Du YZ, et al. (2007). Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces 58:157–64
- Zhang Z, Lv H, Zhou J. (2009). Novel solid lipid nanoparticles as carriers for oral administration of insulin. Pharmazie 64:574–8